The new acquisition is Lilly's ninth since the start of the year, coming just a few weeks after it agreed to buy psychedelic ...
A new, universal definition for a heart attack or myocardial infarction (MI) recognises that there are many different ...
Since 2001, International Overdose Day has been observed as a moment to remember those lost to overdose and renew society’s ...
Since taking effect in August 2024, the EU AI Act (Regulation (EU) 2024/1689) has categorised AI tools by risk level. For ...
Developing new drugs and therapies is a contact sport for research sites. Investigators are on the frontlines, meeting and ...
As the European Society of Cardiology Congress 2026 kicks off today, UK biopharma company Isomab has presented landmark ...
After a series of bumps in the road, Roviant and Priovant Therapeutics have finally secured US approval for the once-daily oral TYK2/JAK1 inhibitor, Lisraya (brepocitinib), for adults with ...
The MHS technology is Anthropic’s first tool designed to operate in the physical world. According to the Financial Times, ...
The FDA issued approvals for Pfizer and Moderna's 2026 COVID-19 vaccines on Thursday, but is recommending them for the same ...
US President Donald Trump has nominated White House health policy aide Heidi Overton to take up the mantle of commissioner ...
Sanofi is laying off 229 former Blueprint Medicines employees in Cambridge, MA and closing two legacy Blueprint facilities.
Lantheus Holdings, Inc., a Bedford, Massachusetts-headquartered radiopharmaceutical-focused company, announced on 14 th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results